Does CAC testing alter downstream treatment patterns for cardiovascular disease?

Area of Science:

• Cardiology
• Preventive Medicine
• Health Services Research

Background:

• Coronary artery calcium (CAC) scans are used to assess cardiovascular risk.
• The impact of CAC scans on clinical decision-making and patient outcomes requires further investigation, particularly in non-high-risk populations.

Purpose of the Study:

• To evaluate if CAC scans alter treatment patterns, including cardiac imaging and interventions.
• To determine the effect of CAC scans on subsequent ischemic events in patients.
• To identify inappropriate CAC testing in high-risk individuals.

Main Methods:

• A longitudinal observational study analyzed data from a large managed-care database (2005-2011).
• Two cohorts were compared: patients who received CAC scans and a reference group denied CAC scans.
• Outcomes were analyzed for non-high-risk patients to assess the impact of CAC scores on risk classification and subsequent care.

Main Results:

• Among non-high-risk patients, CAC scans did not significantly change rates of cardiac imaging, revascularization, or pharmaceutical interventions within 6 months.
• Adverse ischemic events were rare and not significantly different between groups.
• A notable proportion of high-risk patients, for whom CAC testing is often considered inappropriate, underwent testing.

Conclusions:

• CAC scans did not lead to fewer downstream ischemic events or reduced subsequent interventions in non-high-risk patients.
• The findings suggest that CAC testing may be inappropriately applied to high-risk individuals.
• Further research is needed to optimize the use of CAC scans in cardiovascular risk assessment.